Wales Cancer Biobank
http://walescancerbank.com/
The Wales Cancer Bank (WCB) was set up in 2004 and consented the first patient in 2005. The project is hosted by Cardiff University and receives funding from the Welsh Government, Cancer Research Wales and Velindre Charitable funds. A Cancer Bank is literally a collection of tissue and blood which has been collected from patients where cancer is a possible diagnosis and is being stored to facilitate future research into cancer. Statistics suggest that four out of ten people will be diagnosed with cancer at some point during their life. Cancers are complex diseases and it is an on-going quest to understand how they develop, spread and can be treated. The development of more effective, targeted treatment for cancer depends on increased understanding of the molecular mechanisms involved in the initiation of the tumour, its progression to metastatic disease and response and resistance to treatment. Research studies rely on the availability of high quality biological material from patients with cancer and large studies are needed to correlate biology with clinical outcome. The Welsh population is relatively stable and this makes it an ideal cohort to collect and study. Linkage with the all Wales cancer clinical database (CANISC) enables good correlation of science with clinical follow-up. This will eventually enable the results from hundreds of research projects to be integrated and linked to clinical outcome and this will be an invaluable source of data for bioinformatics specialists to examine. All the data collected is being stored on a database housed in the NHS to ensure security and confidentiality The WCB currently consents patients in 12 hospitals around Wales with specially trained research nurses and clinical teams.
Services
- Tissue micro array creation
- Nucleic acid extraction
Existing samples:
- Hodgkin's disease (disorder)
- Malignant neoplasm of connective tissue (disorder)
- Malignant neoplasm of endometrium of corpus uteri (disorder)
- Malignant neoplasm of skin (disorder)
- Malignant neoplasm of upper respiratory tract (disorder)
- Malignant tumor of adrenal gland (disorder)
- Malignant tumor of anal canal (disorder)
- Malignant tumor of biliary tract (disorder)
- Malignant tumor of breast (disorder)
- Malignant tumor of cervix (disorder)
- Malignant tumor of colon (disorder)
- Malignant tumor of kidney (disorder)
- Malignant tumor of lung (disorder)
- Malignant tumor of nasal sinuses (disorder)
- Malignant tumor of oral cavity (disorder)
- Malignant tumor of ovary (disorder)
- Malignant tumor of pancreas (disorder)
- Malignant tumor of penis (disorder)
- Malignant tumor of prostate (disorder)
- Malignant tumor of salivary gland (disorder)
- Malignant tumor of small intestine (disorder)
- Malignant tumor of stomach (disorder)
- Malignant tumor of testis (disorder)
- Malignant tumor of thyroid gland (disorder)
- Malignant tumor of urinary bladder (disorder)
- Malignant tumor of vagina (disorder)
- Malignant tumor of vulva (disorder)
- Malignant tumour of oesophagus
Networks
- Confederation of Cancer Biobanks The NCRI’s Confederation of Cancer Biobanks (CCB) is a consortium of biobanks and biosample collections based in the UK, established to encourage greater coordination and promote harmonisation between biobanks – enabling them to share best practice and raise awareness of their collections with researcher
- Scientist.com Our collaboration with UK CRC TCC is to simplify and improve the access to human biosamples. We understand that it is vital that a Biobank has fully visibility to the research organisation, the researcher to be conducted and control who samples are provided to. As such we have built our platform specifically to address these requirements. Through the platform a biobank can get immediate access to: • A contract specifically designed for the provision of biospecimens that has been accepted by all our clients and results in a direct contractual relationship between the researcher and biobank. • Access to our COMPLi functionality to simplify and speed up the process to work with researchers • Access to a dedicated team to support your biobank in responding to request. • A cost neutral solution to support sustainability within the biobank community. Our work supporting the provision of human biospecimens began in 2014 and since then we have launched our COMPLi™ functionality to support and facilitate over 6500 projects, involving the sourcing of human samples, by removing the administrative burden whilst supporting sustainability within Biobanks. Our aim is to facilitate direct, controlled interactions between the sources of samples and researchers that results in a direct contractual relationship and supports the required level of transparency needed by both parties. If you are interested in joining the platform please do not hesitate to get in touch. Background Founded in 2007, Scientist.com is the world's leading and fastest-growing marketplace for outsourced scientific services and human biological samples. Scientist.com significantly simplifies research by saving time and money and providing easy access to innovative tools and technologies - while maintaining full compliance with an organization’s procurement policies be that researcher or provider. We operate private marketplaces for most of the world’s major pharmaceutical companies and the US National Institutes of Health (NIH); other clients include large and small biotechnology companies, academic researchers and citizen scientists.
Contact Information
- Email:
- parry-jonesa@cf.ac.uk
- Address:
-
Cardiff University
A2, Main Building
University Hospital of Wales
Heath Park
Cardiff
Cardiff
CF14 4XN
Wales
Last Updated: 05/09/2023
Annual Statistics
Year | Access Requests Received | Access Requests Approved | ||||
---|---|---|---|---|---|---|
Internal | External | Commercial | Internal | External | Commercial | |
2015 | N/A | N/A | N/A | N/A | N/A | N/A |
2016 | N/A | N/A | N/A | N/A | N/A | N/A |
2017 | N/A | N/A | N/A | N/A | N/A | N/A |
2018 | N/A | N/A | N/A | N/A | N/A | N/A |
2019 | N/A | N/A | N/A | N/A | N/A | N/A |
2020 | N/A | N/A | N/A | N/A | N/A | N/A |
2021 | N/A | N/A | N/A | N/A | N/A | N/A |
2022 | N/A | N/A | N/A | N/A | N/A | N/A |
2023 | N/A | N/A | N/A | N/A | N/A | N/A |
2024 | N/A | N/A | N/A | N/A | N/A | N/A |